Five global research leaders named University Scholars

Recipients are considered global leaders in a number of diverse research areas and academic disciplines.

June 5, 2017

Experts Featured In This Story

Chandrima Chakraborty
Chandrima Chakraborty

Professor

See Profile
Wael El-dakhakhni
Wael El-dakhakhni

Professor

See Profile
Peter Nyers
Peter Nyers

Professor

See Profile
Paul McNicholas
Paul McNicholas

Professor

See Profile
Sheila Singh
Sheila Singh

Professor (Part-Time)

See Profile

Five McMaster researchers have been named University Scholars.

Wael El-Dakhakhni (Civil Engineering), Chandrima Chakraborty (English and Cultural Studies), Sheila Singh (Surgery), Paul McNicholas (Mathematics and Statistics) and Peter Nyers (Political Science) have all been recognized for distinguishing themselves as international scholars.

Recipients are considered global leaders in a number of diverse research areas and academic disciplines.

Each University Scholar will be awarded for a period of four years and will receive $15,000 per year provided by McMaster Provost David Wilkinson and the applicable Faculty dean.

A couple walking on a path, one of them using a walker for assistance.

McMaster researchers identify genetic factors linked to frailty

Understanding what influences frailty opens the door to earlier screening and personalized approaches to supporting healthy aging, researchers say
A close-up of a vial containing a clear peptide blend of BPC-157 and TB-500, next to two single-use syringes.

What do we know about ‘research only’ peptides? Q&A with expert Stuart Phillips 

Unapproved peptides that lack safety and efficacy data carry substantial risks and belong in a laboratory, not your body, Phillips warns.
Scientist Jon Stokes stands in a university corridor, wearing a hoodie and ball cap.

McMaster researcher awarded more than $2M from Weston Family Foundation to advance precision antibiotic for IBD

The funding will accelerate the move toward human trials, enabling preclinical studies, regulatory preparation and early-phase clinical trial design.